Press Releases

BASEL, Switzerland, May 14, 2024 /PRNewswire/ -- New research, presented today at the 10th European Stroke Organisation Conference (ESOC) 2024, has revealed that high-income individuals have a 32% lower risk of post-stroke mortality. Additionally, those with a higher education have a 26% lower risk of death post-stroke, highlighting striking disparities in stroke survival based on key social determinants of health (SDoH).

The study analysed data from 6,901 stroke... (continue reading...)

Sojitz intends to use its extensive network to help Ginkgo foster business connections within the Japanese bioeconomy

TOKYO and BOSTON, May 14, 2024 /PRNewswire/ -- Sojitz, a large Japanese general trading company with extensive networks within the Japanese bioeconomy, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that they have entered into a binding definitive agreement. Together,... (continue reading...)

Reassessment demonstrates the company’s evolving SSE portfolio is secure for use by Australian federal entities

SAN JOSE, Calif.--(BUSINESS WIRE)-- Skyhigh Security, a member of Oracle PartnerNetwork (OPN), today announced its Skyhigh Security Service Edge (SSE) Portfolio has completed an updated Australian Information Security Registered Assessors Program (IRAP) assessment to include Skyhigh Cloud Firewall and Oracle Cloud Infrastructure (OCI). The latest... (continue reading...)

AUBURN, Ala., May 14, 2024 (GLOBE NEWSWIRE) -- On May 14, 2024, the Board of Directors of Auburn National Bancorporation, Inc. (the “Company”) (Nasdaq: AUBN) declared a second quarter $0.27 per share cash dividend, payable June 25, 2024 to shareholders of record as of June 10, 2024.

About Auburn National Bancorporation, Inc.

Auburn National Bancorporation, Inc. (the “Company”) is the parent company of AuburnBank (the “Bank”), with total assets... (continue reading...)

• Company ended the quarter with $29.5 million in cash
• DETECT-trial recruitment completed; Company continues to expect the completion of the trial in the second quarter and top-line data in the third quarter of 2024
• All-stock merger of equals transaction with Ceapro Inc. expected to close in the second quarter of 2024

TORONTO, ONTARIO, May 14, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty... (continue reading...)